PRKDC and cancer: Since DNA-PK is a critical component of the damage response machinery and taken in consideration that a high number of cancer treatments produce irreparable DNA damage, its expression correlates with decreased response to DNA damaging agents, and therefore therapeutic resistance in multiple cancers [32,33,34], including breast [35,36].